UK has low prescribing rates for Alzheimer’s drug

Community Care Market News (News) November 2002The UK is at the bottom of the prescribing league table for Alzheimer’s disease drugs, according to research commissioned by pharmaceutical companies Pfizer Ltd and Eisai who co-market the Alzheimer’s disease drug Aricept. The survey, conducted by Taylor Nelson Sofres, found that the UK had the lowest use of…